SuperworthADC Therapeutics SA market cap ADCT
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $183.8M
- Highest close in our data
- $2.3B
- Aug 2021
ADC Therapeutics SA is worth $183.8M at the close on Oct 23, 2026, at $1.44 a share.
That is down 60% over the last year and down 92% over five years.
Its highest close in our data was $2.3B in Aug 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $183.8M | $127.2M | $543.7M | −58% |
| 2025 | $434.8M | $116.9M | $532.7M | +122% |
| 2024 | $196.3M | $146.8M | $426.6M | +47% |
| 2023 | $133.9M | $37.9M | $387.9M | −55% |
| 2022 | $295M | $238.1M | $1.5B | −81% |
| 2021 | $1.5B | $1.5B | $2.3B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest ADC Therapeutics SA's size, closest first, today.
| Company | Market cap |
|---|---|
| ADCTADC Therapeutics SA | $183.8M |
| NATRNatures Sunshine Products | $213.8M |
| LFVNLifevantage | $73.4M |
| ARVNArvinas | $477.3M |
| SPROSpero Therapeutics | $64.6M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on ADC Therapeutics SA
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.